BioSpace News Archive

Drug Development

Equillium and Biocon Announce Positive COVID-19 Data for Plaque Psoriasis Drug Itolizumab

Itolizumab is a first-in-class monoclonal antibody that selectively targets the CD6-ALCAM pathway.

July 13, 2020
·
3 min read
·
Mark Terry
Business

Studies Suggest Blood Type May Impact the Severity of COVID-19 Cases

In general, studies have shown that people with Type O blood appear to be more protected than those with Type A, who are seemingly more vulnerable, according to NBC News.

July 13, 2020
·
2 min read
·
Krystle Vermes
Drug Development

Biopharma Update on the Novel Coronavirus: July 13

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 13, 2020.

July 13, 2020
·
3 min read
·
BioSpace Editorial Staff
Business

Ovid and Angelini Pharma Ink $222 Million Angelman Syndrome Partnership

Angelman Syndrome is a genetic disorder that mostly affects the nervous system.

July 13, 2020
·
3 min read
·
Mark Terry
BioCapital

Can – and Should – Pharma Manufacturing Heed Calls to Come Home?

The COVID-19 pandemic underscored weaknesses in critical industries in the U.S. In the pharmaceutical industry, the global nature of the business, long considered a benefit, became not just a weakness but a national security threat.

July 13, 2020
·
4 min read
·
Gail Dutton
Drug Development

Genentech’s Tecentriq-Avastin Combo Fails to Hit Primary Endpoint in Ovarian Cancer

Although the trial failed to meet the primary endpoint of PFS, the data for overall survival as a co-primary endpoint is not yet mature. The company plans to continue the trial until the next planned analysis.

July 13, 2020
·
2 min read
·
Mark Terry
Policy

BioNTech, Pfizer Snag Fast Track Designation for Two COVID-19 Vaccine Candidates

The designation will provide for an expedited pathway for regulatory review of the preventative medication, which could come later this year.

July 13, 2020
·
2 min read
·
Alex Keown
Business

Merck, Dewpoint Collaborate to Develop Potential HIV Curative Treatment

Boston-based Dewpoint Therapeutics and Merck will collaborate to develop a novel mechanism for the treatment of HIV by harnessing Dewpoint’s proprietary platform for condensate-based drug discovery.

July 13, 2020
·
2 min read
·
Alex Keown
TNF Inhibitors Market: Rise in geriatric population with increasing incidence of inflammatory conditions create lucrative opportunity

The global TNF inhibitors market was valued around US$ 40,369.8 Mn in 2017.

July 13, 2020
·
5 min read
Understanding Impact of COVID-19 on Membrane Microfiltration Market

As per the latest research study by TMR, the membrane microfiltration market is anticipated to witness an impressive growth at a CAGR of over 7.5% through 2028.

July 13, 2020
·
4 min read